Puma Biotechnology, Inc.
PBYI
$2.98
-$0.02-0.67%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 100.97M | 96.73M | 96.83M | 107.16M | 95.94M |
Total Receivables | 32.01M | 54.64M | 28.11M | 24.58M | 47.84M |
Inventory | 8.72M | 2.67M | 9.05M | 7.10M | 7.08M |
Prepaid Expenses | 1.83M | 881.00K | 1.67M | 1.51M | 2.48M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 4.13M | 1.90M | 2.07M | 2.67M | 2.85M |
Total Current Assets | 147.66M | 156.82M | 137.72M | 143.03M | 156.19M |
|
|||||
Total Current Assets | 147.66M | 156.82M | 137.72M | 143.03M | 156.19M |
Net Property, Plant & Equipment | 5.09M | 6.02M | 6.91M | 7.78M | 8.65M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 51.13M | 53.57M | 56.00M | 58.44M | 60.87M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 9.45M | 4.32M | 4.37M | 4.91M | 4.83M |
Total Assets | 213.33M | 220.72M | 205.00M | 214.15M | 230.53M |
|
|||||
Total Accounts Payable | 5.51M | 7.51M | 13.50M | 8.96M | 6.89M |
Total Accrued Expenses | 26.07M | 33.22M | 22.10M | 21.29M | 35.63M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 50.87M | 50.68M | 50.49M | 50.31M | 38.80M |
Total Finance Division Other Current Liabilities | 13.66M | 18.99M | 18.21M | 17.63M | 18.07M |
Total Other Current Liabilities | 13.66M | 18.99M | 18.21M | 17.63M | 18.07M |
Total Current Liabilities | 96.11M | 110.40M | 104.30M | 98.19M | 99.38M |
|
|||||
Total Current Liabilities | 96.11M | 110.40M | 104.30M | 98.19M | 99.38M |
Long-Term Debt | 21.72M | 32.75M | 43.74M | 54.69M | 65.66M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 1.49M | 2.95M | 4.36M | 5.74M | 7.03M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.88M | 3.54M | 4.10M | 4.55M | 5.01M |
Total Liabilities | 121.21M | 149.63M | 156.49M | 163.17M | 177.09M |
|
|||||
Common Stock & APIC | 1.41B | 1.41B | 1.40B | 1.40B | 1.40B |
Retained Earnings | -1.31B | -1.33B | -1.35B | -1.35B | -1.35B |
Treasury Stock & Other | 6.00K | 26.00K | -32.00K | -26.00K | -4.00K |
Total Common Equity | 92.13M | 71.09M | 48.51M | 50.98M | 53.44M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 92.13M | 71.09M | 48.51M | 50.98M | 53.44M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 92.13M | 71.09M | 48.51M | 50.98M | 53.44M |
|